NuGen Medical Devices Inc.
NGMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,010 | $331 | $152 | $138 |
| % Growth | 204.7% | 117.5% | 10.7% | – |
| Cost of Goods Sold | $488 | $167 | $706 | $45 |
| Gross Profit | $522 | $165 | -$553 | $92 |
| % Margin | 51.7% | 49.7% | -363.1% | 67% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,034 | $7,522 | $4,241 | $1,716 |
| SG&A Expenses | $5,034 | $7,522 | $4,241 | $7,764 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $6,048 |
| Other Operating Expenses | $646 | $691 | $0 | $0 |
| Operating Expenses | $5,679 | $8,213 | $4,241 | $7,764 |
| Operating Income | -$5,157 | -$8,048 | -$4,794 | -$7,671 |
| % Margin | -510.7% | -2,428.5% | -3,146.6% | -5,573.1% |
| Other Income/Exp. Net | -$62 | -$1,280 | -$781 | $567 |
| Pre-Tax Income | -$5,219 | -$9,328 | -$5,575 | -$7,104 |
| Tax Expense | $7 | $34 | $3 | $3 |
| Net Income | -$5,226 | -$9,362 | -$5,578 | -$7,107 |
| % Margin | -517.5% | -2,825% | -3,661.1% | -5,163.2% |
| EPS | -0.024 | -0.056 | -0.062 | -0.1 |
| % Growth | 56.3% | 9.9% | 38.1% | – |
| EPS Diluted | -0.024 | -0.056 | -0.062 | -0.1 |
| Weighted Avg Shares Out | 214,420 | 167,667 | 90,102 | 68,675 |
| Weighted Avg Shares Out Dil | 214,420 | 167,665 | 90,102 | 68,675 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $151 | $0 |
| Interest Expense | $1,669 | $1,236 | $1,011 | $1,223 |
| Depreciation & Amortization | $646 | $691 | $577 | $627 |
| EBITDA | -$2,905 | -$7,401 | -$4,217 | -$5,165 |
| % Margin | -287.6% | -2,233.3% | -2,767.8% | -3,752.4% |